semaglutide constipation lawsuit in louisiana law firm Ozempic for Blindness, Stomach Paralysis and Injury Claims Patients claim blindness, bowel injuries

The similar risk reductions observed in clinically defined ALD, laboratory-defined ALD (HR 0.36), and ALD requiring medications (HR 0.32) suggest that semaglutides benefits extend beyond subjective clinical assessments to include objective laboratory parameters and treatment needs

Medical Evaluation Before Initiation Doctors may assess the patients medical history, including blood sugar levels, gastrointestinal health, and other underlying conditions before prescribing Semaglutide Tablet to ensure suitability

The pattern observed in TRIUMPH-4: 2 mg: ~13% mean weight loss 4 mg: ~17% mean weight loss 8 mg: ~24% mean weight loss 12 mg: ~28.7% mean weight loss This positions retatrutide as the first agent capable of routinely producing weight loss greater than 25% territory previously reached only by bariatric surgery

S., Han, K., Lee, H

Less common but important side effects include hypoglycaemia (particularly when used with insulin or sulfonylureas), injection site reactions, and gallbladder problems (cholelithiasis, cholecystitis)